L3VLUP
ProSign in

LIVN in the 13F filings

Livanova PLC · CUSIP G5509L101

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2023
the date the book describes
Filed
14 Nov 2023
latest of these filings; the earliest 14 Nov 2023
Managers listing it
6
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2023 and Q3 2023; 4 listed it in both
Shares listed
5,535,330
combined, among listed positions
Reported value
$293m
combined, at the quarter end

Managers listing LIVN in Q3 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

6 of 6 holders

ActionFiling
Millennium Management LLC1,965,536$104m0.05%Addedn.a.14 Nov 2023 (the filing on sec.gov)
AllianceBernstein LP1,499,114$79munder 0.1%Trimmed-726,24914 Nov 2023 (the filing on sec.gov)
Point72 Asset Management LP1,137,813$60m0.18%Addedn.a.14 Nov 2023 (the filing on sec.gov)
Marshall Wace LLP890,603$47m0.10%Added+281,99414 Nov 2023 (the filing on sec.gov)
Element Capital Management LLC37,091$2.0m0.17%Trimmed-3,67914 Nov 2023 (the filing on sec.gov)
Maverick Capital Ltd5,173$274kunder 0.1%Trimmed-716,15814 Nov 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2023 to Q3 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
9 in Q3 2024 to 6 in Q2 2026

Tracked managers listing it, at least.

05101520162017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
LIVN by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20153$203mn.a.n.a.
Q1 20164$174mn.a.n.a.
Q2 20164$152mn.a.n.a.
Q3 20162$154mn.a.n.a.
Q4 20164$174mn.a.n.a.
Q1 20174$195mn.a.n.a.
Q2 20178$404mn.a.n.a.
Q3 20178$746mn.a.n.a.
Q4 20178$646mn.a.n.a.
Q1 201812$843mn.a.n.a.
Q2 201810$941mn.a.n.a.
Q3 201815$1.0bnn.a.n.a.
Q4 201811$758mn.a.n.a.
Q1 201910$601mn.a.n.a.
Q2 20198$579mn.a.n.a.
Q3 20197$813mn.a.n.a.
Q4 20196$663mn.a.n.a.
Q1 20203$215mn.a.n.a.
Q2 20209$346mn.a.n.a.
Q3 20207$358mn.a.n.a.
Q4 20205$373mn.a.n.a.
Q1 20213$390mn.a.n.a.
Q2 20216$550mn.a.n.a.
Q3 20219$674mn.a.n.a.
Q4 20218$753mn.a.n.a.
Q1 20226$662mn.a.n.a.
Q2 20227$563mn.a.n.a.
Q3 20225$330mn.a.n.a.
Q4 20226$222mn.a.n.a.
Q1 20237$99mn.a.n.a.
Q2 20237$204mn.a.n.a.
Q3 20236$293mn.a.n.a.
Q4 20237$300m54
Q1 20246$290m32
Q2 20247$364m52
Q3 20249$465m72
Q4 202413$457m103
Q1 20259$332m81
Q2 20257$332m34
Q3 20256$390m33
Q4 20258$673m1216
Q1 20267$491m1512
Q2 20266$583m1317

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

LIVN and LLY →LIVN and JNJ →LIVN and VRTX →Choose a stock to compare with LIVN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own LIVN, latest filings →Back to the 13F Explorer →